Abstract
Lenalidomide (also known as Revlimid((R)), CC-5013) is an immunomodulatory derivative of thalidomide and has more potent anti-tumor and anti-inflammatory effects than thalidomide. The molecular mechanisms of anti-tumor activity of lenalidomide have been extensively studied in multiple myeloma (MM) both preclinical models and in clinical trials. Lenalidomide: directly triggers growth arrest and/or apoptosis of drug resistant MM cells; inhibits binding of MM cells to bone marrow (BM) extracellular matrix proteins and stromal cells; modulates cytokine secretion and inhibits angiogenesis in the BM milieu; and augments host anti-tumor immunity. Lenalidomide achieved responses in patients with relapsed refractory MM. Moreover, lenalidomide with dexamethasone (Dex) demonstrates more potent anti-MM activities than Dex both in vitro and in randomized phase III clinical trials. Specifically, the combination improved overall and extent of response, as well as prolonged time to progression and overall survival, resulting in FDA approval of lenalidomide with Dex for therapy MM relapsing after prior therapy.
Citations
Apr 21, 2010·Medical Oncology·Thomas ReskeNikhil C Munshi
Mar 19, 2013·Chemistry Central Journal·Nasr Y KhalilAbdel-Rahman A Al-Majed
Jul 24, 2010·Blood·Güllü GörgünKenneth C Anderson
Jun 4, 2010·Radiation Research·Dan JiaRobert J Griffin
Apr 11, 2015·Future Oncology·María J Cejalvo, Javier de la Rubia
Nov 26, 2014·Nature Reviews. Clinical Oncology·Meletios A DimopoulosKenneth C Anderson
Nov 7, 2019·Biomolecules·Javad Sharifi-RadWilliam C Cho
Nov 20, 2008·Current Treatment Options in Oncology·Peter H Wiernik
Apr 28, 2016·Oncotarget·Shaunna L BeedieNeil Vargesson
Apr 11, 2020·Clinical Case Reports·Rajeev RamakrishnaTerry Golombick
Jul 17, 2018·Current Medicinal Chemistry·Sureyya Olgen, Lakshmi P Kotra
Aug 9, 2018·Future Medicinal Chemistry·Krzysztof Z Łączkowski, Angelika Baranowska-Łączkowska
Dec 5, 2008·Expert Opinion on Investigational Drugs·George J Brewer
Jun 1, 2012·Therapeutic Advances in Drug Safety·Gordon F RushworthClaire Vincent
Feb 20, 2010·Medical Oncology·Jacob P LaubachKenneth C Anderson
Jan 16, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James R BerensonRobert Vescio
Aug 17, 2021·Journal of Epilepsy Research·Elaheh Asgari DafeAhmad Reza Dehpour
May 27, 2009·Journal of Pharmaceutical and Biomedical Analysis·Zhi-Yi ZhangVikram V Kansra